Strides Pharma Science, 532531, STAR Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,924.55
15.66
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

9,530.54
0.47%
2.70

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.78
6.60
7.37

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.68
4.94
15.67

PAT CAGR (%)

10 Years
5 Years
3 Years

13.60
2.84
132.95

P:E (Median)

8 Years
5 Years
3 Years

5.95
-
-

P:BV (Average)

8 Years
5 Years
3 Years

2.21
2.51
3.00

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.65
15.89
11.87

Earnings Forecasts:

(Updated: 31-01-2026)

Description 2024 2025 2026 2027
Adj EPS 390.55 55.3 69.4 96.4
P/E Ratio 1.24 8.76 6.98 5.03
Revenue 4565.33 4859.4 5612.2 6521
EBITDA 802.81 944.9 1110.4 1382.2
Net Income 3593.45 509.9 639.9 888.8
ROA 60.45
P/B Ratio 1.75 1.47 1.24 1.02
ROE 153.65 18.1 19.3 22.3
FCFF 216.8 443.4 512.8 674.9
FCFF Yield 2.4 4.9 5.67 7.46
Net Debt 1673.35
BVPS 276.88 329.97 389.4 473.83

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 553.63 550.92 0.49% 522.15 609.96 -14.40% 498.62 554.75 -10.12% 555.96 617.63 -9.98%
Expenses 472.43 476.82 -0.92% 459.93 546.93 -15.91% 431.39 493.72 -12.62% 488.03 526.84 -7.37%
EBITDA 81.20 74.10 9.58% 62.22 63.03 -1.29% 67.23 61.03 10.16% 67.93 90.79 -25.18%
EBIDTM 14.67% 13.45% 11.92% 10.33% 13.48% 11.00% 12.22% 14.70%
Other Income 103.24 2.43 4,148.56% 14.09 23.55 -40.17% 1.76 11.83 -85.12% 12.12 29.63 -59.10%
Interest 27.24 34.21 -20.37% 29.41 50.15 -41.36% 30.45 46.88 -35.05% 29.36 46.77 -37.22%
Depreciation 22.39 20.92 7.03% 21.51 21.98 -2.14% 22.14 20.32 8.96% 22.37 20.81 7.50%
PBT 134.80 21.38 530.50% 25.39 14.43 75.95% 16.40 5.66 189.75% 28.32 52.78 -46.34%
Tax 12.91 6.44 100.47% -6.65 -0.88 - 3.06 1.74 75.86% 12.20 -0.89 -
PAT 121.90 14.94 715.93% 32.04 15.31 109.27% 13.35 3.92 240.56% 16.13 53.66 -69.94%
PATM 22.02% 2.71% 6.14% 2.51% 2.68% 0.71% 2.90% 8.69%
EPS 13.22 1.62 716.05% 3.48 1.66 109.64% 1.45 0.43 237.21% 1.75 5.82 -69.93%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 1,194.65 1,153.67 3.55% 1,220.83 1,201.11 1.64% 1,119.74 1,087.50 2.96% 1,190.39 1,084.04 9.81%
Expenses 958.70 943.35 1.63% 989.26 965.30 2.48% 901.66 870.52 3.58% 972.52 854.30 13.84%
EBITDA 235.94 210.31 12.19% 231.57 235.81 -1.80% 218.07 216.98 0.50% 217.87 229.73 -5.16%
EBIDTM 19.75% 18.23% 18.97% 19.63% 19.48% 19.95% 18.30% 21.19%
Other Income 106.86 5.62 1,801.42% 27.14 28.41 -4.47% 8.58 12.72 -32.55% 11.98 -13.55 -
Interest 43.38 52.18 -16.86% 46.13 82.15 -43.85% 47.46 80.39 -40.96% 50.32 80.16 -37.23%
Depreciation 50.62 48.42 4.54% 49.64 50.52 -1.74% 48.89 48.59 0.62% 48.86 49.76 -1.81%
PBT 245.51 112.89 117.48% 154.17 127.67 20.76% 121.94 96.98 25.74% 103.25 78.20 32.03%
Tax 37.35 23.80 56.93% 21.59 21.20 1.84% 16.45 16.86 -2.43% 20.76 19.25 7.84%
PAT 208.15 89.09 133.64% 132.57 106.47 24.51% 105.49 80.12 31.67% 82.49 58.95 39.93%
PATM 17.42% 7.72% 10.86% 8.86% 9.42% 7.37% 6.93% 5.44%
EPS 21.93 9.54 129.87% 13.84 10.14 36.49% 10.81 7.64 41.49% 8.92 1.98 350.51%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,130.36 2,139.42 1,866.12 1,854.50 1,979.00 1,857.57 1,691.93 1,537.44 1,955.40 1,381.82 2,221.63 Net Sales Growth -8.70% 14.65% 0.63% -6.29% 6.54% 9.79% 10.05% -21.37% 41.51% -37.80% Cost Of Goods Sold 1,078.80 1,083.54 969.16 1,065.61 1,101.52 988.87 891.96 878.83 781.25 734.46 1,282.09 Gross Profit 1,051.56 1,055.89 896.96 788.89 877.49 868.70 799.97 658.61 1,174.15 647.36 939.55 GP Margin 49.36% 49.35% 48.07% 42.54% 44.34% 46.77% 47.28% 42.84% 60.05% 46.85% 42.29% Total Expenditure 1,851.78 1,888.05 1,724.32 1,771.77 1,902.37 1,698.33 1,487.47 1,403.10 1,815.21 1,269.85 1,953.73 Power & Fuel Cost - 36.00 47.90 45.54 43.76 45.82 44.53 39.77 33.08 25.82 74.12 % Of Sales - 1.68% 2.57% 2.46% 2.21% 2.47% 2.63% 2.59% 1.69% 1.87% 3.34% Employee Cost - 377.59 348.92 267.01 272.09 272.72 230.23 223.21 224.53 228.48 274.16 % Of Sales - 17.65% 18.70% 14.40% 13.75% 14.68% 13.61% 14.52% 11.48% 16.53% 12.34% Manufacturing Exp. - 191.36 196.84 189.99 151.87 153.93 140.73 121.12 106.78 108.28 103.48 % Of Sales - 8.94% 10.55% 10.24% 7.67% 8.29% 8.32% 7.88% 5.46% 7.84% 4.66% General & Admin Exp. - 89.19 62.35 84.63 136.15 115.41 120.08 74.99 79.18 80.46 111.16 % Of Sales - 4.17% 3.34% 4.56% 6.88% 6.21% 7.10% 4.88% 4.05% 5.82% 5.00% Selling & Distn. Exp. - 98.49 75.99 98.01 177.44 94.08 21.02 24.40 26.53 27.80 75.28 % Of Sales - 4.60% 4.07% 5.28% 8.97% 5.06% 1.24% 1.59% 1.36% 2.01% 3.39% Miscellaneous Exp. - 11.90 23.17 20.99 19.55 27.50 38.91 40.78 563.85 64.55 75.28 % Of Sales - 0.56% 1.24% 1.13% 0.99% 1.48% 2.30% 2.65% 28.84% 4.67% 1.51% EBITDA 278.58 251.37 141.80 82.73 76.63 159.24 204.46 134.34 140.19 111.97 267.90 EBITDA Margin 13.08% 11.75% 7.60% 4.46% 3.87% 8.57% 12.08% 8.74% 7.17% 8.10% 12.06% Other Income 131.21 57.26 67.42 99.82 123.48 117.08 93.07 114.61 1,001.72 169.06 109.12 Interest 116.46 145.91 139.38 138.68 74.24 65.34 66.84 54.09 81.97 71.96 102.62 Depreciation 88.41 84.61 87.41 93.62 104.37 99.34 94.24 83.00 114.77 70.01 102.69 PBT 204.91 78.11 -17.57 -49.76 21.51 111.64 136.44 111.85 945.18 139.06 171.70 Tax 21.52 18.93 1.34 -69.44 -158.68 33.40 16.17 -2.04 24.21 15.36 14.71 Tax Rate 10.50% 24.24% -5.84% 107.23% -737.70% 29.92% 11.85% -1.88% 2.64% 12.40% 10.15% PAT 183.42 59.16 -24.27 4.68 180.19 78.24 120.28 110.37 891.59 108.54 130.20 PAT before Minority Interest 183.42 59.16 -24.27 4.68 180.19 78.24 120.28 110.37 891.59 108.54 130.20 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.61% 2.77% -1.30% 0.25% 9.11% 4.21% 7.11% 7.18% 45.60% 7.85% 5.86% PAT Growth 108.84% - - -97.40% 130.30% -34.95% 8.98% -87.62% 721.44% -16.64% EPS 19.89 6.42 -2.63 0.51 19.54 8.49 13.05 11.97 96.70 11.77 14.12

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 4,725.61 4,565.34 3,890.13 3,688.39 3,070.25 3,315.87 2,981.12 3,108.33 3,344.37 3,826.22 2,862.19 Net Sales Growth 4.40% 17.36% 5.47% 20.13% -7.41% 11.23% -4.09% -7.06% -12.59% 33.68% Cost Of Goods Sold 1,921.46 1,979.96 1,749.05 1,626.88 1,502.32 1,332.79 1,122.48 1,085.20 1,378.84 1,281.17 1,502.29 Gross Profit 2,804.15 2,585.37 2,141.07 2,061.50 1,567.93 1,983.08 1,858.64 2,023.14 1,965.53 2,545.05 1,359.90 GP Margin 59.34% 56.63% 55.04% 55.89% 51.07% 59.81% 62.35% 65.09% 58.77% 66.52% 47.51% Total Expenditure 3,822.14 3,767.56 3,317.89 3,303.09 3,091.76 2,689.06 2,470.90 2,811.65 3,108.66 3,309.30 2,481.62 Power & Fuel Cost - 58.17 75.13 85.82 71.54 64.58 64.49 54.39 51.33 33.87 77.18 % Of Sales - 1.27% 1.93% 2.33% 2.33% 1.95% 2.16% 1.75% 1.53% 0.89% 2.70% Employee Cost - 862.76 737.05 732.02 646.91 550.15 442.56 329.44 434.05 419.16 357.69 % Of Sales - 18.90% 18.95% 19.85% 21.07% 16.59% 14.85% 10.60% 12.98% 10.95% 12.50% Manufacturing Exp. - 311.98 299.81 259.45 255.52 237.94 210.79 150.98 115.97 137.47 119.23 % Of Sales - 6.83% 7.71% 7.03% 8.32% 7.18% 7.07% 4.86% 3.47% 3.59% 4.17% General & Admin Exp. - 221.56 198.06 232.21 223.67 191.73 191.89 150.10 194.38 172.63 198.71 % Of Sales - 4.85% 5.09% 6.30% 7.29% 5.78% 6.44% 4.83% 5.81% 4.51% 6.94% Selling & Distn. Exp. - 298.20 215.03 263.65 331.30 223.22 137.07 111.22 208.85 161.12 129.57 % Of Sales - 6.53% 5.53% 7.15% 10.79% 6.73% 4.60% 3.58% 6.24% 4.21% 4.53% Miscellaneous Exp. - 34.93 43.76 103.06 60.51 88.65 301.61 930.33 725.25 1,103.88 129.57 % Of Sales - 0.77% 1.12% 2.79% 1.97% 2.67% 10.12% 29.93% 21.69% 28.85% 3.39% EBITDA 903.45 797.78 572.24 385.30 -21.51 626.81 510.22 296.68 235.71 516.92 380.57 EBITDA Margin 19.12% 17.47% 14.71% 10.45% -0.70% 18.90% 17.12% 9.54% 7.05% 13.51% 13.30% Other Income 154.56 63.76 49.85 135.22 133.40 59.44 66.70 322.90 920.64 398.08 102.37 Interest 187.29 248.85 280.22 261.14 176.74 150.06 155.72 79.29 196.24 183.10 168.17 Depreciation 198.01 192.26 213.64 243.25 233.01 206.29 187.79 171.85 193.93 198.69 131.25 PBT 624.87 420.42 128.22 16.11 -297.88 329.90 233.42 368.44 766.17 533.20 183.50 Tax 96.15 77.52 29.11 -55.30 -178.26 31.65 17.91 14.49 21.41 51.19 42.45 Tax Rate 15.39% 15.98% -47.86% 6010.87% 32.91% 8.48% 11.50% 3.71% 2.96% 10.30% 29.87% PAT 528.70 405.34 -120.20 -221.20 -460.21 352.32 143.62 370.31 681.31 399.38 113.21 PAT before Minority Interest 509.29 409.40 -143.90 -230.90 -474.25 341.61 137.82 375.57 701.18 445.58 99.68 Minority Interest -19.41 -4.06 23.70 9.70 14.04 10.71 5.80 -5.26 -19.87 -46.20 13.53 PAT Margin 11.19% 8.88% -3.09% -6.00% -14.99% 10.63% 4.82% 11.91% 20.37% 10.44% 3.96% PAT Growth 58.00% - - - - 145.31% -61.22% -45.65% 70.59% 252.78% EPS 57.34 43.96 -13.04 -23.99 -49.91 38.21 15.58 40.16 73.89 43.32 12.28

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 3,192.74 3,527.60 3,455.05 3,406.68 3,248.06 3,158.79 3,256.80 3,162.02 3,232.53 3,157.63 Share Capital 92.16 91.90 90.30 89.79 89.68 89.56 89.55 89.50 89.42 89.35 Total Reserves 3,100.06 3,432.61 3,345.33 3,314.44 3,153.66 3,063.50 3,159.68 3,063.45 3,134.25 3,062.51 Non-Current Liabilities 108.36 170.19 272.63 108.27 307.43 -37.31 -63.12 -34.41 795.22 876.55 Secured Loans 127.37 202.32 284.74 124.69 147.54 0.00 0.15 2.44 769.45 861.40 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 51.68 46.34 33.32 33.47 207.17 20.58 12.88 13.32 22.58 10.14 Current Liabilities 1,629.61 2,085.14 1,796.83 1,841.32 1,590.64 1,454.94 1,388.99 1,104.05 1,434.15 1,244.88 Trade Payables 484.85 543.76 643.44 643.80 735.20 489.87 509.40 390.72 470.56 497.17 Other Current Liabilities 169.73 236.78 153.81 108.43 136.11 93.08 49.36 73.51 290.27 195.69 Short Term Borrowings 951.93 1,284.28 984.57 1,068.64 693.50 852.45 808.80 601.59 647.44 543.38 Short Term Provisions 23.10 20.33 15.00 20.45 25.82 19.54 21.44 38.22 25.87 8.65 Total Liabilities 4,930.71 5,782.93 5,524.51 5,356.27 5,146.13 4,576.42 4,582.67 4,231.66 5,461.90 5,279.06 Net Block 756.02 735.60 584.30 604.09 576.66 578.35 496.73 497.96 1,123.76 983.58 Gross Block 1,479.95 1,446.15 1,182.95 1,128.61 1,012.07 923.74 746.47 676.58 1,339.89 1,080.89 Accumulated Depreciation 723.93 710.55 598.65 524.52 435.41 345.39 249.74 178.62 216.13 97.31 Non Current Assets 2,785.21 3,371.76 3,398.10 3,381.03 3,402.26 3,180.89 2,919.09 2,732.11 2,882.74 2,633.43 Capital Work in Progress 105.68 107.48 55.38 55.72 110.67 112.25 122.46 143.86 157.75 180.09 Non Current Investment 1,847.69 2,363.59 2,491.77 2,399.76 2,462.48 2,242.91 2,071.47 1,531.19 1,310.77 1,307.94 Long Term Loans & Adv. 50.88 145.96 245.47 304.95 247.32 237.29 223.27 154.76 204.04 154.66 Other Non Current Assets 14.02 7.52 8.92 3.70 5.13 10.10 5.16 404.35 86.41 7.16 Current Assets 2,145.50 2,411.18 2,126.40 1,975.25 1,743.86 1,395.53 1,663.59 1,499.54 2,579.16 2,645.62 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 154.29 311.48 1,279.54 1,139.10 Inventories 431.71 498.07 490.76 513.06 689.08 462.82 473.34 269.63 409.53 379.23 Sundry Debtors 1,452.93 1,565.04 1,307.78 1,296.32 821.66 655.61 582.56 449.37 540.68 692.40 Cash & Bank 30.50 115.10 85.58 14.45 73.04 109.90 180.81 79.79 94.92 94.34 Other Current Assets 230.36 126.51 92.60 83.67 160.07 167.20 272.58 389.29 254.49 340.55 Short Term Loans & Adv. 118.76 106.46 149.68 67.75 80.42 89.14 123.06 175.88 122.37 95.54 Net Current Assets 515.89 326.04 329.58 133.92 153.22 -59.42 274.59 395.49 1,145.00 1,400.74 Total Assets 4,930.71 5,782.94 5,524.50 5,356.28 5,146.12 4,576.42 4,582.68 4,231.65 5,461.90 5,279.05

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,551.83 2,125.57 2,212.26 2,359.23 2,776.66 2,527.42 2,648.70 2,463.66 2,748.82 2,657.87 Share Capital 92.16 91.90 90.30 89.79 89.68 89.56 89.55 89.50 89.42 89.35 Total Reserves 2,459.16 2,030.57 2,102.54 2,266.99 2,682.26 2,432.13 2,551.59 2,365.10 2,650.55 2,562.75 Non-Current Liabilities 601.61 621.44 1,210.30 965.72 1,264.45 813.65 2,342.88 2,067.29 2,048.67 2,760.03 Secured Loans 558.47 618.40 1,040.81 744.86 873.43 601.79 1,806.45 1,551.09 1,622.87 2,614.88 Unsecured Loans 12.78 53.10 98.98 90.77 9.15 2.12 0.06 0.23 14.84 12.13 Long Term Provisions 113.94 91.63 73.42 64.28 246.50 63.95 52.24 16.55 25.19 14.45 Current Liabilities 2,591.52 2,879.26 2,990.20 3,411.68 2,738.35 2,544.86 2,662.24 1,899.30 3,103.87 1,891.98 Trade Payables 1,032.50 851.59 982.34 1,071.52 1,134.20 797.75 888.99 712.07 774.09 775.40 Other Current Liabilities 307.41 341.57 527.89 697.18 421.00 354.49 248.12 129.98 819.08 347.93 Short Term Borrowings 1,136.36 1,574.15 1,330.76 1,496.53 1,023.84 1,228.78 1,339.02 944.39 1,393.96 700.48 Short Term Provisions 115.25 111.94 149.20 146.43 159.31 163.84 186.11 112.86 116.73 68.19 Total Liabilities 5,779.59 5,572.41 6,373.38 6,760.72 6,816.80 5,953.17 7,806.77 6,584.90 8,034.86 7,360.09 Net Block 1,888.12 1,853.18 2,298.42 2,333.45 2,151.13 2,025.85 3,570.13 2,903.00 2,909.03 2,678.68 Gross Block 2,897.25 2,873.18 3,324.82 3,231.69 2,841.28 2,534.38 4,049.05 3,229.03 3,186.12 2,825.43 Accumulated Depreciation 1,009.14 1,020.00 1,026.40 898.24 690.15 508.53 478.92 326.03 277.09 146.75 Non Current Assets 2,680.68 2,603.41 3,130.03 3,398.88 3,999.57 3,581.05 4,758.05 4,101.31 4,243.05 3,845.20 Capital Work in Progress 206.76 161.89 150.98 291.08 447.37 412.95 453.03 620.29 780.18 814.88 Non Current Investment 339.71 196.93 438.96 540.34 666.23 503.24 494.34 350.08 315.66 127.19 Long Term Loans & Adv. 140.19 256.13 217.18 210.58 185.80 210.82 223.69 197.22 222.56 201.83 Other Non Current Assets 94.73 123.38 11.91 10.26 549.04 428.19 16.86 30.72 15.62 22.62 Current Assets 3,098.91 2,969.00 3,135.25 3,361.83 2,817.23 2,372.11 3,048.72 2,483.59 3,791.82 3,514.89 Current Investments 69.50 105.76 50.84 0.00 99.41 118.97 284.75 311.48 1,279.54 1,213.76 Inventories 1,277.57 1,126.24 1,146.51 1,173.80 1,200.70 782.54 874.16 552.02 732.80 613.14 Sundry Debtors 1,202.94 1,141.87 1,299.40 1,207.30 1,110.59 931.69 987.18 882.18 995.91 1,032.97 Cash & Bank 136.78 191.17 315.96 187.35 179.76 237.10 516.65 303.33 329.48 311.59 Other Current Assets 412.12 228.99 169.21 647.90 226.76 301.81 385.98 434.59 454.09 343.44 Short Term Loans & Adv. 135.92 174.97 153.34 145.49 128.54 218.24 249.11 295.75 244.39 97.54 Net Current Assets 507.39 89.74 145.05 -49.84 78.89 -172.75 386.48 584.29 687.95 1,622.91 Total Assets 5,779.59 5,572.41 6,265.28 6,760.71 6,816.80 5,953.16 7,806.77 6,584.90 8,034.87 7,360.09

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 421.48 -14.01 241.74 -282.69 282.76 137.63 39.97 65.59 411.74 83.08 PBT 2,905.14 40.99 -64.76 21.51 111.64 136.44 108.33 915.80 123.90 144.91 Adjustment -2,622.75 250.90 172.87 75.17 114.15 130.28 90.19 -670.77 193.49 156.46 Changes in Working Capital 16.58 -359.60 33.81 -400.77 -109.81 -96.91 -121.04 -161.75 131.16 -168.93 Cash after chg. in Working capital 298.97 -67.71 141.92 -304.09 115.97 169.81 77.48 83.28 448.55 132.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 122.52 53.71 99.82 21.41 166.79 -32.17 -37.52 -17.68 -36.81 -49.36 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -137.59 -69.56 -182.58 18.78 -275.64 62.83 -166.06 447.36 -344.05 -1,063.90 Net Fixed Assets -32.00 -315.30 -54.00 -61.59 -86.75 -167.06 -48.49 677.20 -236.66 -535.93 Net Investments 515.90 128.18 -92.01 62.72 -219.57 -17.15 -383.09 747.64 -143.27 -1,478.58 Others -621.49 117.56 -36.57 17.65 30.68 247.04 265.52 -977.48 35.88 950.61 Cash from Financing Activity -370.32 93.34 10.82 250.73 -48.64 -203.56 123.26 -706.77 -67.24 1,570.84 Net Cash Inflow / Outflow -86.42 9.77 69.98 -13.18 -41.52 -3.09 -2.83 -193.82 0.45 590.03 Opening Cash & Equivalents 92.75 82.11 12.12 25.30 66.82 69.91 72.30 280.52 818.84 264.05 Closing Cash & Equivalent 6.33 92.75 82.11 12.12 25.30 66.82 69.47 72.30 280.52 818.84

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 684.37 701.07 44.41 -257.81 481.44 204.79 60.05 187.07 288.14 73.25 PBT 3,675.03 -62.72 -267.63 -652.51 289.38 48.51 344.37 705.80 497.14 146.44 Adjustment -2,893.97 818.27 682.19 582.27 363.31 527.49 94.59 -274.51 190.92 345.56 Changes in Working Capital -163.72 -78.73 -457.80 -189.90 -328.05 -326.23 -323.14 -190.66 -341.30 -341.71 Cash after chg. in Working capital 617.34 676.82 -43.23 -260.14 324.64 249.76 115.82 240.63 346.76 150.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 67.04 24.25 87.64 2.33 156.80 -44.98 -55.76 -53.56 -58.62 -77.04 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -89.69 -150.25 302.47 -118.73 -520.82 1,306.16 -148.49 582.59 -686.69 -2,224.83 Net Fixed Assets -32.00 -315.30 -54.00 -61.59 -86.75 -167.06 -48.49 677.20 -236.66 -535.93 Net Investments 515.90 128.18 -92.01 62.72 -219.57 -17.15 -383.09 747.64 -143.27 -1,478.58 Others -573.59 36.87 448.48 -119.86 -214.50 1,490.37 283.09 -842.25 -306.76 -210.32 Cash from Financing Activity -642.58 -693.32 -213.92 421.32 -15.80 -1,709.45 194.27 -1,015.69 338.21 2,943.94 Net Cash Inflow / Outflow -47.90 -142.51 132.96 44.77 -55.18 -198.50 105.83 -246.03 -60.33 792.35 Opening Cash & Equivalents 161.02 303.50 170.73 125.83 182.23 365.89 256.16 515.08 1,110.74 298.91 Closing Cash & Equivalent 112.56 161.02 303.50 170.73 125.83 182.23 365.89 256.16 515.08 1,110.74

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 346.37 383.52 380.46 379.13 361.65 352.04 362.84 352.29 360.50 352.77 ROA 1.10% -0.43% 0.09% 3.43% 1.61% 2.63% 2.50% 18.40% 2.02% 2.98% ROE 1.76% -0.70% 0.14% 5.42% 2.45% 3.76% 3.45% 27.96% 3.40% 5.63% ROCE 4.71% 2.34% 1.56% 2.18% 4.35% 5.03% 4.15% 23.18% 4.10% 7.52% Fixed Asset Turnover 1.46 1.42 1.60 1.85 1.92 2.03 2.16 1.94 1.14 2.51 Receivable days 257.44 280.95 256.27 195.32 145.14 133.56 122.49 92.40 162.86 77.91 Inventory Days 79.31 96.70 98.79 110.86 113.17 100.98 88.19 63.39 104.17 43.92 Payable days 173.25 223.56 220.46 228.47 226.09 127.51 117.56 116.72 143.54 64.74 Cash Conversion Cycle 163.51 154.10 134.60 77.70 32.22 107.02 93.13 39.07 123.49 57.08 Total Debt/Equity 0.36 0.46 0.39 0.37 0.27 0.27 0.25 0.19 0.50 0.49 Interest Cover 1.54 0.84 0.53 1.29 2.71 3.04 3.00 12.17 2.72 2.41

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 276.83 230.95 242.83 262.48 309.09 281.55 294.94 274.26 306.41 296.83 ROA 7.21% -2.41% -3.52% -6.99% 5.35% 2.00% 5.22% 9.59% 5.79% 2.03% ROE 17.52% -6.67% -10.15% -18.49% 12.91% 5.34% 14.74% 27.00% 16.53% 5.25% ROCE 16.56% 3.47% -0.49% -9.49% 11.17% 6.01% 8.65% 16.07% 10.75% 7.54% Fixed Asset Turnover 2.46 1.96 1.91 1.75 2.04 1.50 1.17 1.04 1.27 1.47 Receivable days 60.35 73.17 73.25 79.41 68.09 70.88 79.95 102.49 96.77 90.73 Inventory Days 61.86 68.12 67.80 81.35 66.13 61.20 61.00 70.11 64.20 52.34 Payable days 173.66 191.36 230.40 267.95 264.54 138.58 146.59 116.23 117.33 75.51 Cash Conversion Cycle -51.45 -50.07 -89.35 -107.20 -130.32 -6.50 -5.64 56.37 43.64 67.55 Total Debt/Equity 0.70 1.14 1.27 1.18 0.76 0.78 1.22 1.03 1.35 1.34 Interest Cover 2.96 0.59 -0.10 -2.69 3.49 2.00 5.92 4.68 3.71 1.85

Top Investors:

quant mutual fund - quant multi cap fund

route one offshore master fund, l.p.

sbi life insurance co. ltd

route one fund i, l.p.

morgan stanley asia (singapore) pte. - odi

satpal khattar

authum investment and infrastructure limited

axis mutual fund trustee ltd a/c axis mutual fund

mukul mahavir agrawal

oman india joint investment fund ii

Annual Reports:

News Update:

Strides Pharma’s arm receives USFDA closure report for New York Formulations Facility
5th Feb 2026, 10:58 AM

The successful closure of inspection further strengthens the company’s U.S. business and near-term growth prospects
Read More
Strides Pharma Scien - Quarterly Results
31st Jan 2026, 00:00 AM

Read More
USFDA concludes cGMP inspection at formulations facility of Strides Pharma’s arm
26th Dec 2025, 10:23 AM

At the conclusion of the inspection, the USFDA has issued a Form 483 with four observations
Read More

Strides Pharma Science Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532531 | NSE: STAR

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Strides Pharma Science Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532531 | NSE: STAR

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: